Libtayo plus chemotherapy is potentially more cost-effective than Keytruda plus chemotherapy for advanced NSCLC, offering lower costs and higher QALYs. The study's model, based on clinical trial data, ...
The second-line use of CDK4/6 inhibitors in advanced breast cancer saves substantial costs while maintaining health outcomes ...
This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease ...
Researchers from MD Anderson Cancer Center found that laparoscopy cost more upfront but eliminated wasteful treatment decisions. A cost-effective analysis has shown that using laparoscopy to guide the ...
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
Data sources Medline, Embase, Web of Science, Scopus, National Institute for Health Research Economic Evaluation Database, Health Technology Assessment database, Tufts Cost-Effectiveness Analysis ...
Massachusetts legislators have drafted two bills that propose banning the use of cost-effectiveness analysis to inform healthcare coverage decisions. The proposals state that employing measures of ...
The Boca Raton Government Campus Redevelopment Project is facing another hurdle as a Boca Raton resident asks a district ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback